国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱(chēng) 貨號(hào) 規(guī)格
Recombinant Ficedula parva Cytochrome b (MT-CYB), partial CSB-YP857700FBAM
CSB-EP857700FBAM
CSB-BP857700FBAM
CSB-MP857700FBAM
CSB-EP857700FBAM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sylvicapra grimmia Cytochrome b (MT-CYB), partial CSB-YP857701SFAM
CSB-EP857701SFAM
CSB-BP857701SFAM
CSB-MP857701SFAM
CSB-EP857701SFAM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cephalophus nigrifrons Cytochrome b (MT-CYB), partial CSB-YP857702CMAM
CSB-EP857702CMAM
CSB-BP857702CMAM
CSB-MP857702CMAM
CSB-EP857702CMAM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica NADH-ubiquinone oxidoreductase chain 3 (ND3), partial CSB-YP857703YAP1
CSB-EP857703YAP1
CSB-BP857703YAP1
CSB-MP857703YAP1
CSB-EP857703YAP1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica Cytochrome c oxidase subunit 1 (COX1), partial CSB-YP857704YAP
CSB-EP857704YAP
CSB-BP857704YAP
CSB-MP857704YAP
CSB-EP857704YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ostrinia nubilalis Cytochrome c oxidase subunit 1 (COI), partial CSB-YP857705OFQ
CSB-EP857705OFQ
CSB-BP857705OFQ
CSB-MP857705OFQ
CSB-EP857705OFQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida albicans ATP synthase subunit a (ATP6), partial CSB-YP857706CZD1
CSB-EP857706CZD1
CSB-BP857706CZD1
CSB-MP857706CZD1
CSB-EP857706CZD1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Elaphodus cephalophus NADH-ubiquinone oxidoreductase chain 4L (MT-ND4L), partial CSB-YP857707EEAH1
CSB-EP857707EEAH1
CSB-BP857707EEAH1
CSB-MP857707EEAH1
CSB-EP857707EEAH1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Hypseleotris compressa Cytochrome b (mt-cyb), partial CSB-YP857708HFAS
CSB-EP857708HFAS
CSB-BP857708HFAS
CSB-MP857708HFAS
CSB-EP857708HFAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chamaerops humilis ATP synthase subunit beta, chloroplastic (atpB) CSB-YP857709CMAN
CSB-EP857709CMAN
CSB-BP857709CMAN
CSB-MP857709CMAN
CSB-EP857709CMAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Amphidinium carterae Photosystem Q (B) protein (psbA), partial CSB-YP857710AJA1
CSB-EP857710AJA1
CSB-BP857710AJA1
CSB-MP857710AJA1
CSB-EP857710AJA1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant NAD (P)H-quinone oxidoreductase subunit I, chloroplastic (ndhI) CSB-YP857711LQQ
CSB-EP857711LQQ
CSB-BP857711LQQ
CSB-MP857711LQQ
CSB-EP857711LQQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant 50S ribosomal protein L16, chloroplastic (rpl16) CSB-YP857712LQQ
CSB-EP857712LQQ
CSB-BP857712LQQ
CSB-MP857712LQQ
CSB-EP857712LQQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Photosystem II reaction center protein H (psbH), partial CSB-YP857713LQQ1
CSB-EP857713LQQ1
CSB-BP857713LQQ1
CSB-MP857713LQQ1
CSB-EP857713LQQ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cytochrome b559 subunit alpha (psbE), partial CSB-YP857714LQQ1
CSB-EP857714LQQ1
CSB-BP857714LQQ1
CSB-MP857714LQQ1
CSB-EP857714LQQ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant 30S ribosomal protein S2, chloroplastic (rps2) CSB-YP857715LQQ
CSB-EP857715LQQ
CSB-BP857715LQQ
CSB-MP857715LQQ
CSB-EP857715LQQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Photosystem II reaction center protein Z (psbZ), partial CSB-YP857716LQQ1
CSB-EP857716LQQ1
CSB-BP857716LQQ1
CSB-MP857716LQQ1
CSB-EP857716LQQ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant NAD (P)H-quinone oxidoreductase subunit 3, chloroplastic (ndhC), partial CSB-YP857717LQQ1
CSB-EP857717LQQ1
CSB-BP857717LQQ1
CSB-MP857717LQQ1
CSB-EP857717LQQ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mouse Selenoprotein S (Sels), partial CSB-YP857718MO1
CSB-EP857718MO1
CSB-BP857718MO1
CSB-MP857718MO1
CSB-EP857718MO1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Panthera tigris altaica Follitropin subunit beta (FSHB) CSB-YP857719PHAS
CSB-EP857719PHAS
CSB-BP857719PHAS
CSB-MP857719PHAS
CSB-EP857719PHAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶(hù)提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€(xiàn)留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>